Engimplan, a Materialise Company, was founded in 2019 as a result of the merger of Engimplan, established in 1992, and Materialise, a company with three decades of experience in software solutions and services in additive manufacturing (3D printing). The company specializes in developing high-value solutions in implants and instruments, with a focus on cranio-maxillofacial (CMF) surgeries. The products are known for their high technology, quality, reliability, and innovation, meeting the strictest standards of national and international inspection agencies. Engimplan is a pioneer in implant customization, providing unique solutions for patients worldwide, reflecting its slogan "Better. Healthier. Together we can create a world driven by innovation." In terms of industries, Engimplan operates in the manufacturing sector, leveraging its expertise in 3D printing and additive manufacturing technologies. Though specific details about its headquarters, last investment, and investors are not available, the company's potential lies in its long-standing experience, innovative products, and partnerships with renowned companies. Engimplan's commitment to pushing the boundaries of traditional medical solutions reinforces its position as a key player in the evolving healthcare technology landscape.
There is no investment information
No recent news or press coverage available for Materialise CMF Brazil.